Clinical Trials Logo

Clinical Trial Summary

Reducing the time patients spend in the labor and delivery room saves money and reduces patient discomfort as well and reducing complications. We will compare two methods for inducing cervical maturation in order to shorten the time taken between administration of drugs and delivery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03194126
Study type Interventional
Source Centre Hospitalier Universitaire de Nimes
Contact
Status Completed
Phase N/A
Start date February 11, 2018
Completion date September 25, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT02694198 - Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion N/A
Completed NCT01860521 - Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Termination of Pregnancy Analgesia N/A
Withdrawn NCT04304365 - Home Follow-up After Medication Abortion N/A
Completed NCT03400358 - Uterocervical Angle in the Pregnancy Termination of Multiparous Women N/A
Recruiting NCT05342467 - Gemeprost Versus Dinoprostone in First Trimester Miscarriages Phase 2
Recruiting NCT03269279 - Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso Phase 3
Completed NCT02381223 - Simplified Medical Abortion Screening: A Pilot Demonstration Project N/A
Recruiting NCT05940233 - Comparison of Rate of Complete Abortion Between Letrozole Plus Misoprostol vs Misoprostol Alone N/A
Not yet recruiting NCT03570307 - Fertility and Obstetric Outcomes After Medical Management Versus Surgical Treatment for First-trimester Miscarriage First-trimester Miscarriage N/A
Completed NCT01943279 - Comparison of Telephone Follow-up With In-person Follow-up After Medical Abortion N/A
Not yet recruiting NCT04194658 - Effectiveness of Pretreatment Letrozole Versus Misoprostol Alone in Missed Abortion Phase 2
Completed NCT01966874 - Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation Phase 2/Phase 3